CIK 0001863127
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Tyra Biosciences, Inc.
Sign in to watch- Ticker
- TYRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 831476348
- Phone
- +1 619-728-4760
- Business address
- 2656 STATE STREET, CARLSBAD, CA, 92008
- Open-market buys, last 90 days
- $20,000
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$20,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-12 | Bensen Daniel Chief Discovery Officer | Sale 10b5-1 | −2,128 | $31.50 | $67K | 152,853 |
| 2026-02-12 | Bensen Daniel Chief Discovery Officer | Sale 10b5-1 | −5,872 | $33.37 | $196K | 146,981 |
| 2026-01-12 | Bensen Daniel Chief Discovery Officer | Sale 10b5-1 | −6,983 | $28.44 | $199K | 155,998 |
| 2026-01-12 | Bensen Daniel Chief Discovery Officer | Sale 10b5-1 | −1,017 | $29.08 | $30K | 154,981 |
| 2025-12-12 | Bensen Daniel Chief Discovery Officer | Sale 10b5-1 | −8,000 | $22.64 | $181K | 162,981 |
| 2025-11-19 | Bensen Daniel Chief Operating Officer | Sale 10b5-1 | −49,956 | $16.32 | $815K | 170,981 |
| 2025-11-18 | Bensen Daniel Chief Operating Officer | Sale 10b5-1 | −75,633 | $16.07 | $1.2M | 220,937 |
| 2025-11-17 | Bensen Daniel Chief Operating Officer | Sale 10b5-1 | −18,572 | $16.11 | $299K | 298,070 |
| 2025-11-17 | Bensen Daniel Chief Operating Officer | Sale 10b5-1 | −1,500 | $17.07 | $26K | 296,570 |
| 2025-11-14 | Bensen Daniel Chief Operating Officer | Sale 10b5-1 | −110,228 | $16.02 | $1.8M | 316,642 |
| 2025-11-13 | Bensen Daniel Chief Operating Officer | Sale 10b5-1 | −1,111 | $16.00 | $18K | 426,870 |
| 2025-08-07 | Bensen Daniel Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +170,000 | 170,000 | ||
| 2024-08-14 | Bensen Daniel Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +115,000 | 115,000 | ||
| 2024-06-10 | Bensen Daniel Chief Operating Officer | Sale 10b5-1 | −3,502 | $20.00 | $70K | 427,981 |
| 2024-06-07 | Bensen Daniel Chief Operating Officer | Sale 10b5-1 | −200 | $20.00 | $4K | 431,483 |
| 2024-03-11 | Bensen Daniel Chief Operating Officer | Sale 10b5-1 | −200 | $20.00 | $4K | 431,683 |
| 2024-03-07 | Bensen Daniel Chief Operating Officer | Sale 10b5-1 | −68 | $20.00 | $1K | 431,883 |
| 2024-03-06 | Bensen Daniel Chief Operating Officer | Sale 10b5-1 | −1,733 | $20.09 | $35K | 431,951 |
| 2024-03-05 | Bensen Daniel Chief Operating Officer | Sale 10b5-1 | −1,189 | $20.02 | $24K | 433,684 |
| 2024-03-04 | Bensen Daniel Chief Operating Officer | Sale 10b5-1 | −5,063 | $20.08 | $102K | 434,873 |
Page 1 of 6 · 117 trades